Project Grant HT94252510541
Award Date
9/1/25
Completion Date
8/31/29
Dollars Obligated
$2.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Oklahoma City, OK 73104, USA
Similar Awards
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $676,117 to The Children's Hospital of Philadelphia Research Institute to conduct research on expanded GAA-GGA chimeric repeats in Friedreich ataxia. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical research to address critical health challenges. The award period runs...
This Project Grant award from the Department of Defense's Defense Health Agency provides $313,000.00 to the University of Massachusetts Lowell to conduct research on how small and weak muscles develop in Friedreich's ataxia patients. The research aims to improve understanding of this neurological disorder that affects service members and veterans. The award is funded under the Military Medical Research and Development CFDA program (12.420), which supports a range of biomedical research to...
The University of Florida (UF) Division of Sponsored Research has been awarded a $2,235,400 Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420). The award, effective April 1, 2024 through March 31, 2028, will support research on the "Contribution of Repeat Associated Non-AUG (RAN) Proteins in Friedreich's and Other Hereditary Ataxias." This project grant is part of the Military Medical Research and Development program, which...
This $315,958 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by Rush University Medical Center to investigate the neural underpinnings of the relationship between cognitive and gait dysfunction in Fragile X-associated Tremor/Ataxia Syndrome (FXTAS). The award period runs from September 30, 2024 to September 29, 2026. This research aims to transform health care for...
This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
The University of Florida Division of Sponsored Research was awarded a $745,408 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on April 1, 2024, will support research on the "Contribution of Repeat Associated Non-AUG (RAN) Proteins in Friedreich's and Other Hereditary Ataxias" over a 4-year period through March 31, 2028. This research aims to advance the understanding and...
The University of Oklahoma Health Sciences Center was awarded a $427,109 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) on May 15, 2025. The grant supports research to investigate "TARGETING DCLK1-MEDIATED GLUTAMINE ADDICTION IN CHEMORESISTANT OVARIAN CANCER METASTASES", with a performance period ending on May 14, 2027. The Military Medical Research and Development program funds a diverse portfolio of advanced biomedical...
This federal Project Grant award, totaling $431,750.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant will support research conducted by the University of Houston System to investigate the role of H19X noncoding RNAs in the pathogenesis of myotonic dystrophy type I. The award duration is from December 1, 2024 to November 30, 2026. The Military Medical Research and Development program funds advanced biomedical...
This $240,897 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, will support integrative transcriptomic and epigenomic profiling of subependymal giant cell astrocytoma at single-cell resolution. The award was made to Duke University's Office of Research Administration on August 1, 2025, with a period of performance through July 31, 2027. The Military Medical Research and Development program funds advanced biomedical...
The University of Texas Southwestern Medical Center was awarded a $2,641,871 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from May 1, 2023 through April 30, 2027 to comprehensively upregulate and stabilize frataxin mRNA using antisense oligonucleotides. The goal of this research is to transform health care for service members and the public by investigating medical solutions for the...